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Abstract 
Proteinopathies result from aberrant folding and accumulation of specific proteins. Currently, there is a 
lack of knowledge about the factors that influence disease progression making this a key challenge for 
the development of therapies for proteinopathies. Due to the similarities between transmissible 
spongiform encephalopathies (TSEs) and other protein misfolding diseases, TSEs can be used to 
understand other proteinopathies. Bovine spongiform encephalopathy (BSE) is a TSE that occurs in cattle 
and can be subdivided into three strains: classical BSE, and atypical BSEs (H-type and L-type) that have 
shorter incubation periods. The NLRP3 inflammasome is a critical component of the innate immune 
system that leads to release of IL-1β (Interlukin-1β). Macroautophagy is an intracellular mechanism that 
plays an essential role in protein clearance. In this study, we use the retina as a model to investigate the 
relationship between disease incubation period, prion protein (PrPSc) accumulation, neuroinflammation, 
and changes in macroautophagy. We demonstrate that atypical BSEs present with increased PrPSc 
accumulation and neuroinflammation, and decreased autophagy. Our work suggests a relationship 
between disease time course, neuroinflammation, and the autophagic stress response. This work may 
help identify novel therapeutic biomarkers that can delay or prevent the progression of proteinopathies. 
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Proteinopathies result from aberrant folding and accumulation of specific proteins. Currently, there is a 
lack of knowledge about the factors that influence disease progression making this a key challenge for 
the development of therapies for proteinopathies. Due to the similarities between transmissible 
spongiform encephalopathies (TSEs) and other protein misfolding diseases, TSEs can be used to 
understand other proteinopathies. Bovine spongiform encephalopathy (BSE) is a TSE that occurs in 
cattle and can be subdivided into three strains: classical BSE, and atypical BSEs (H-type and L-type) that 
have shorter incubation periods. The NLRP3 inflammasome is a critical component of the innate 
immune system that leads to release of IL-1β (Interlukin-1β). Macroautophagy is an intracellular 
mechanism that plays an essential role in protein clearance. In this study, we use the retina as a model 
to investigate the relationship between disease incubation period, prion protein (PrPSc) accumulation, 
neuroinflammation, and changes in macroautophagy. We demonstrate that atypical BSEs present with 
increased PrPSc accumulation and neuroinflammation, and decreased autophagy. Our work suggests a 
relationship between disease time course, neuroinflammation, and the autophagic stress response. This 
work may help identify novel therapeutic biomarkers that can delay or prevent the progression of 
proteinopathies.  
Key words: autophagy, bovine spongiform encephalopathy, incubation period, NLRP3 inflammasome, 
prion disease, retina.  




Many neurodegenerative diseases, including Parkinson’s disease (PD), Alzheimer’s disease (AD), 
Huntington’s disease (HD), and transmissible spongiform encephalopathies (TSEs) result from protein 
misfolding followed by the subsequent aggregation of these proteins into abnormal, toxic species that 
accumulate in tissues 1-3. A key feature that distinguishes prion diseases from other protein misfolding 
diseases is the transmissibility of TSE agents. While the causative agent of all TSEs is misfolded prion 
protein (PrPSc), different strains of TSEs within a species may be distinguished by different pathogenesis 
and disease phenotypes. These phenotypes include distinct immunohistological characteristics (i.e., 
lesion profiles, neuroanatomical deposition patterns of PrPSc), clinical signs and incubation periods 2, 4-11. 
Specifically, BSE can be subdivided into classical BSE, colloquially known as mad cow disease, and 
sporadic/atypical BSE 4. Atypical BSE can be further subdivided into H-type and L-type, with the H- and L- 
designations based on a higher or lower molecular mass of the unglycosylated PrPSc isoform, when 
compared to classical BSE 4. Both H-type and L-type BSE, herein referred to as BSE-H and BSE-L, have 
shorter incubation periods after experimental intracranial inoculation and, therefore, an accelerated 
disease progression when compared to classical BSE. One of the key challenges for drug discovery and 
development of therapeutic approaches is a lack of well-validated disease biomarkers due to a limited 
understanding of the molecular and cellular factors that interact with the misfolded proteins and 
influence how rapidly a disease progresses 1. Due to the striking parallels of TSEs to the non-infectious 
protein misfolding diseases (i.e., PD, AD,  and HD), prion diseases can be used to study and understand 
other proteinopathies 1. In this study, we exploited the differences between classical and atypical BSEs 
to identify the molecular factors or determinants that are associated with the slower progression of 
classical BSE, versus the more rapid progression of atypical BSEs. Specifically, we use the strain-
dependent variation in incubation periods between classical and atypical BSEs as a controlled 
framework to examine the relationship between a diverse set of immunological characteristics.  
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PrPSc accumulates in retinas of TSE infected animals 12-20, and antemortem changes in retinal function 
and morphology are detectable in BSE inoculated cattle up to 11 months prior to the appearance of any 
other clinical signs of disease suggesting that the retina is an excellent experimental model to 
investigate disease pathogenesis. Accumulation of PrPSc has also been reported in other structures of 
the visual system, including the optic nerve, extraocular muscle, choroid, vitreous, lens, and sclera 20.  
Herein we use the retina as an experimental model to investigate the effect of PrPSc accumulation and 
specific neuroinflammatory processes (including glial cell activation, NLRP3 inflammasome activation, 
and macroautophagy) on disease incubation periods. The NLRP3 inflammasome is a multiprotein 
complex that is an important component of innate immunity and a known contributor to the 
progression of several protein misfolding diseases (i.e., TSEs, PD, and AD) 21, 22. Macroautophagy, often 
referred to as autophagy, is a highly conserved metabolic process responsible for the clearance of bulk 
cytoplasmic components, including protein aggregates. Several studies indicate that misfolded proteins 
provoke microglia-driven NLRP3 inflammasome activation that has been reported to be associated with 
autophagic dysfunction (i.e., a decline in autophagic processes) 21, 23-27. However, the collective effect of 
inflammasome activation and autophagy on disease progression and incubation periods is unknown.  
In this study, we report that disease incubation period is inversely correlated to PrPSc accumulation, glial-
cell activation, and NLRP3 inflammasome activation in the retina, brainstem, and thalamus. Specifically, 
cattle inoculated with atypical BSE-H and BSE-L, characterized by shorter incubation periods compared 
to classical BSE, had greater PrPSc deposition, robust activation of Müller glia, astrocytes, and microglia, 
and microglia-driven NLRP3 inflammasome activation. We show that incubation period accompanies an 
inverse correlation between PrPSc-associated NLRP3 inflammasome activation and autophagy. 
Specifically, we describe opposing events in the autophagic pathway: upregulation of autophagy 
detected in cattle inoculated with classical BSE; and a decline in autophagy in cattle inoculated with BSE-
H or BSE-L that paralleled greater PrPSc accumulation, neuroinflammation and shorter incubation 
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periods. We demonstrate an association between incubation period and several molecular disease 
processes (i.e., accumulation of misfolded proteins, glial cell activation, NLRP3 inflammasome activation, 
and macroautophagy) in vivo, that can further our understanding of the factors that influence disease 
progression. This study provides a better knowledge of the molecular basis of accelerated disease 
progression in different strains of prion disease. Due to the similarity of TSEs with other protein 
misfolding diseases, this work could have important implications for understanding the interplay 
between misfolded proteins and the cellular responses in vivo, and identifying biomarkers that can be 
targeted for clinical trials.  
MATERIALS AND METHODS 
Ethics statement 
This experiment was carried out in accordance with the Guide for the Care and Use of Laboratory 
Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, DC) and 
the Guide for the Care and Use of Agricultural Animals in Research and Teaching (Federation of Animal 
Science Societies, Champaign, IL). The protocol was approved by the Institutional Animal Care and Use 
Committee at the National Animal Disease Center (protocol number: 3985) and Iowa State University 
(protocol number: 7154). 
Animals and inoculum 
Adult Holstein steers (3.8–4.5 years old) were inoculated intracranially with 1 ml of a 10% (wt./vol) brain 
homogenate as previously described 28. Twelve cattle were inoculated with the agent of classical BSE29, 
nine cattle were inoculated with the agent of BSE-H29, and ten cattle were inoculated with the agent of 
BSE-L30. Control cattle (n=5) for this study were sham-inoculated 31, 32. The inoculated cattle were 
observed daily by animal care staff at NADC, and examined regularly by investigators to determine the 
onset of clinical disease. Cattle were euthanized at the onset of unequivocal signs of clinical disease, but 
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were not allowed to develop severe, end-stage disease. Upon euthanasia, all cattle were confirmed 
positive by Western blot or enzyme immunoassay as directed (IDEXX HerdChek BSE-Scrapie Antigen 
ELISA test kit, Westbrook, ME). Tissue collection was performed as previously described 16. Brain 
(cerebral cortex, cerebellum, midbrain, including superior colliculus, brainstem including obex) and eyes 
were collected into 10% buffered formalin (eye globes were fixed in Bouin’s fixative) and embedded in 
paraffin wax for sectioning.  
 
Immunohistochemistry and Western blot analysis 
Paraffin-embedded sections (4 μm) were rehydrated using xylene, followed by a decreasing ethanol 
concentration gradient (100%, 90% 70%), and a final wash with diH2O. Heat-mediated antigen retrieval 
was performed using EDTA buffer (10 mM Trizma Base, 1 mM EDTA solution, 0.05% Tween 20, pH 9.0), 
or citrate buffer (ScyTek Laboratories, Logan, UT) in an autoclave for 30 min. Tissues were incubated 
with Background Buster (Innovex Biosciences Inc., Richmond, CA) for 1.5 h. Primary antibodies against 
glial fibrillary acidic protein (GFAP) (1:1000, Dako, Carpinteria, CA), Iba1 (1:2000, Abcam, Cambridge, 
UK), NLRP3 (1:250, Adipogen, San Diego, USDA), ASC (1:500, Adipogen), caspase-1 (1:1000, Adipogen), 
IL-1β (1:1000, Abcam), LC3A/B (1:2000, Cell Signaling, Danvers, Massachusetts), or caspase-3 (Santa Cruz 
Biotechnology) were diluted in blocking solution containing 0.1% bovine serum albumin (BSA; Sigma-
Aldrich, St. Louis, MO), 0.05% Triton X-100 (Thermo Fisher Scientific, Inc., Rockford, IL) and 5% normal 
serum (Jackson ImmunoResearch, West Grove, PA) in Tris-Buffered saline (TBS), and incubated for 48 h 
at room temperature. Tissues were washed with TBS-T (6 x 5 min) and incubated with a secondary 
antibody cocktail, including CyTM3 and/or Alexa Fluor 488–conjugated AffiniPure secondary antibodies 
(1:250; Jackson ImmunoResearch) and 4’,6-diamidino-2-phenylindole, dilactate (DAPI, 4 µg/mL; Sigma-
Aldrich) for 1.5 h. Following another wash, slides were mounted with Vectashield antifade mounting 
medium (Vector Laboratories Inc., Burlingame, CA). Negative controls were processed in parallel by 
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omission of the primary and/or secondary antibody. For detection of PrPSc, slides were stained by an 
automated immunohistochemical method, described previously 15, 28. The primary antibody used was 
F99/97.6.1 (O’Rourke; Pullman, Washington) at a concentration of 5 μg/ml.  
The protein extraction method for Western blot analysis has been previously described in Mammadova 
et al., 2019 33. The primary antibodies directed against LC3II (1:2500, Cell Signaling), pULK1S757 (1:1000, 
Cell Signaling), ULK1 (1:1500, Cell Signaling), cleaved caspase-1 (p20) (1:1000, Adipogen) and cleaved IL-
1β (p17) (1:2000, Abcam) were incubated overnight at 4°C. All groups are normalized to control and/or 
mock-treated animals, providing a representative of a fold-change from the control, therefore y-axis 
units are arbitrary. Data is representative of 3 biological replicates.  
Fluorescent microscopy and statistical analysis 
We analyzed retinas and brain regions of twelve cattle inoculated with the agent of classical BSE, nine 
cattle inoculated with the agent of BSE-H, ten cattle inoculated with the agent of BSE-L, and five sham-
inoculated cattle. Fluorescence and confocal images were taken at 20x and 60x, using a Nikon A1R+ 
Resonant Scanning Confocal System with a Ti-E inverted microscope and laser lines 405, 488, 561 and 
640 nm (Nikon Instruments Inc., Melville, New York). Micrographs were created using a commercial 
photo-editing system (Adobe Photoshop and Adobe Illustrator [CC]; Adobe Systems). For quantification 
of GFAP, Iba1, NLRP3, and ASC immunoreactivity, the percentage of the total image area limited to a 
threshold (outer limiting membrane to inner limiting membrane of the central retina) was analyzed 
using ImageJ (Rasband, W.S., ImageJ 1.49V, U. S. National Institutes of Health, Bethesda, Maryland, 
imageJ.net, Version 1.52s 15 January 2019), as previously described34. When comparing multiple 
specimens, identical thresholding tool settings (i.e., image acquisition settings and exposure times) were 
used. For each animal, three different sites of the retina were analyzed to gauge for differences in 
immunolabeling: central retina at the thickest section of the retina adjacent to the optic nerve head, and 
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two peripheral retinal locations on opposite sides of the retina within one 20x field of view from the 
peripheral margin. Preliminary analyses showed no significant difference among these sites; therefore, 
data from the peripheral and central retinas was pooled. For each animal, the central retina, near the 
optic disc, within a cross section is represented in our micrographs. For quantification of GFAP, Iba1, 
NLRP3, and ASC immunoreactivity, three consecutive retinal sections (12 μm) were analyzed and the 
mean ± SEM was reported. Equivalent regions of each brain structure (i.e., brainstem at the level of the 
obex, thalamus (interthalamic nuclei), and caudate nuclei) were used for the creation of micrographs 
and quantification using ImageJ. Quantified histological data was analyzed using a two-way ANOVA, with 
a Tukey’s multiple comparisons test (post-hock). Prism 6 for Windows (Graph Pad Software) was used 
for statistical analysis.  
RESULTS 
To investigate the relationship between incubation period and disease associated pathology, we 
conducted a controlled comparison of tissues from cattle experimentally inoculated with classical and 
atypical BSEs (BSE-H and BSE-L). Incubation period for classical BSE, BSE-H or BSE-L is reported as the 
time from intracranial inoculation to the time when unequivocal signs of clinical disease are present. 
Clinical signs of disease included abnormalities in gate and/or stance, moderate to severe ataxia, and 
hyperreaction to stimuli (i.e. noise, movement). Cattle inoculated with atypical BSEs had significantly 
shorter incubation periods compared to cattle inoculated with classical BSE (Fig. 1). The average 
incubation period for cattle inoculated with classical BSE, BSE-H, or BSE-L was 683.7 ± 45.2 dpi, 513.7 ± 
4.8 dpi, and 472.8 ± 11.9 dpi respectively (Fig.1). The differences in incubation period were statistically 
significant (p<0.0001). The migration pattern of PrPSc on Western blot was analyzed to verify that the 
cattle inoculated with classical or atypical BSEs retained a classical, high-type, or low-type migration 
pattern as previously described 13, 30.   
Increased PrP
Sc 
deposition coincides with shorter incubation periods of BSE-H and BSE-L 
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To investigate the relationship between PrPSc deposition and incubation period, PrPSc immunoreactivity 
was assessed in retinas of cattle inoculated with classical BSE, BSE-H, and BSE-L. Retinas from cattle 
inoculated with classical BSE had punctate or granular PrPSc localized primarily to the synaptic layers (IPL 
and OPL in Fig. 2A, B). The distribution of PrPSc labeling was more extensive in retinas of cattle 
inoculated with BSE-H or BSE-L (Fig. 2C, D). Areas of PrPSc immunolabeling was much more intense and 
uniform in the synaptic layers (Fig. 2C, D). Globular deposits of PrPSc were evident in the inner and outer 
segments of photoreceptor cells and dispersed throughout the nuclear layers with robust intracellular 
PrPSc immunoreactivity evident within cells located in the ganglion cell layer (Fig. 2C). Compared to 
retinas of cattle inoculated with BSE-H, PrPSc was rarely detected in the outer segments of 
photoreceptor cells, outer nuclear layer, and ganglion cell layer of BSE-L inoculated cattle (Fig. 2C, D). 
These results demonstrate that increased immunolabeling of PrPSc in the retina correlates with shorter 
incubation periods characteristic of atypical BSEs. To investigate the relationship between PrPSc 
deposition and incubation period in the brain, PrPSc immunoreactivity was assessed in the hypoglossal 
nuclei of the brainstem at the level of the obex, interthalamic nuclei, and caudate nuclei of cattle 
inoculated with classical BSE, BSE-H, and BSE-L. Compared to control, the brainstems at the level of the 
obex of cattle inoculated with classical BSE had aggregated PrPSc deposits (Fig. 2E, F). Compared to cattle 
with classical BSE, PrPSc immunolabeling in the brainstems of cattle inoculated with BSE-H or BSE-L was 
more intense (Fig. 2G, H). A similar trend in PrPSc deposition was seen in the thalami of these cattle (Fig. 
2I-L). Conversely, PrPSc immunolabeling in the caudate nuclei of cattle inoculated with classical BSE, BSE-
H, or BSE-L was similar in the deposition pattern (i.e., aggregated and plaque-like PrPSc deposits) and 
area of immunolabeling (Fig. 2M-P). Strain-dependent differences in incubation time of classical, H-type, 
and L-type BSE did not parallel differences in the amount of PrPSc accumulation in the caudate nuclei. 
Our results demonstrate that increased area of PrPSc deposition in some brain regions (i.e., brainstem 
and thalamus) correlates with shorter incubation times of atypical BSEs.  
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Glial cell activation parallels PrP
Sc 
accumulation 
Activation of Müller glia and microglia is a widely reported retinal response during progression of TSEs, 
like many protein misfolding diseases 12, 13, 15, 35. To assess the activation of these principal retinal glial 
cells, we measured the distribution of GFAP and Iba1 immunoreactivity, respectively. GFAP 
immunoreactivity in quiescent Müller glia is constrained to their endfeet. However, under conditions of 
retinal injury or stress, GFAP expression is increased and widely distributed throughout the radial 
processes of Müller glia that span from the inner limiting membrane to the outer limiting membrane 36. 
GFAP immunoreactivity in the retinas of control cattle was localized to the Müller glial end feet and 
astrocytes in the optic fiber layer (Fig. 3A). Compared to control cattle, the retinas of cattle inoculated 
with classical BSE had increased GFAP immunoreactivity, observed in the radial processes spanning the 
retina from the optic fiber layer to the outer plexiform layer (Fig. 3B). When quantified, there was a 
significant difference in GFAP immunoreactivity between the retinas from cattle inoculated with sham 
and classical BSE (p>0.0001) (Fig. 3I). Compared to the retinas of cattle inoculated with classical BSE, the 
retinas from cattle inoculated with BSE-H or BSE-L had robust GFAP immunoreactivity spanning the 
retina from the optic fiber layer, with hypertrophied Müller glial end feet and activated astrocytes, to 
the outer limiting membrane (Fig. 3B-D). When quantified, GFAP immunoreactivity in retinas of cattle 
inoculated with BSE-H and BSE-L, was significantly greater than that of classical BSE (p<0.01, and p<0.05 
respectively) (Fig. 3I).  
An antibody against Iba1, microglia/macrophage specific calcium binding protein, was used to assess 
activation of microglia in the retinas of all cattle. Assessment of Iba1 immunoreactivity enables the 
analysis of cell shape and morphologic changes of microglia and provides information as to their 
function (i.e., routine surveillance or phagocytosis). Compared to control, retinas of cattle inoculated 
with classical BSE had Iba1 immunoreactive microglia with small somata and thin/long processes, 
sparsely dispersed through the synaptic layers (Fig. 3E, F). Quantification of Iba1 immunoreactivity 
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showed no significant difference between retinas of control cattle and those inoculated with classical 
BSE (Fig. 3J). When compared to retinas from control and classical BSE inoculated cattle, the retinas 
from cattle inoculated with BSE-H or BSE-L had a marked increase in the distribution of Iba1 
immunoreactive microglia and a corresponding change to an amoeboid-like morphology (Fig. 3E-H). Iba1 
immunoreactivity in the retinas from cattle inoculated with atypical BSEs was widely distributed 
throughout all retinal layers with substantially more in synaptic layers and also was detected in the 
neuronal layers and the outer segments (Fig. 3G, H). When quantified, Iba1 immunoreactivity in retinas 
of cattle inoculated with BSE-H and BSE-L, was significantly greater than that of classical BSE (p<0.0001) 
(Fig. 3J).  
To assess the activation of astrocytes and microglia in the brain (i.e., brainstem at the level of the obex, 
thalamus, and caudate nucleus) we measured the distribution and extent of GFAP and Iba1 
immunolabeling, respectively (Supp. Fig. S1 and Supp. Fig. S2). Compared to control, all three brain 
regions of cattle inoculated with classical BSE had significantly more GFAP immunoreactivity (Supp. Fig. 
S1M-O). Compared to classical BSE cattle, GFAP immunoreactivity in the brainstem and thalamus of 
cattle inoculated with BSE-H or BSE-L was stronger (Supp. Fig. S1M, N). Conversely, GFAP 
immunoreactivity in the caudate nuclei of cattle inoculated with classical BSE, BSE-H, or BSE-L was 
comparable in pattern and amount (Supp. Fig. S1O). Similar to the retina, Iba1 immunoreactivity in all 
three brain regions of cattle inoculated with classical BSE, was not significantly different than control 
(Supp. Fig. S2M-O). Compared to classical BSE cattle, Iba1 immunoreactivity in the brainstem and 
thalamus of cattle inoculated with BSE-H or BSE-L was significantly higher (Supp. Fig. S2M-O). Similar to 
PrPSc, and GFAP immunoreactivity, Iba1 immunoreactivity in the caudate nuclei of cattle inoculated with 
classical BSE, BSE-H, or BSE-L was comparable (Supp. Fig. S2O). 
Taken together, these results demonstrate that compared to classical BSE, retinas of BSE-H or BSE-L 
inoculated cattle had robust activation of Mϋller glia, astrocytes, and microglia. These observations 
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correlated with intense PrPSc accumulation, also detected in retinas of BSE-H or BSE-L cattle. Similar 
differences between classical and atypical BSEs were observed in the brainstem and thalamus. However, 
activation of astrocytes and microglia in the caudate nucleus was comparable in cattle inoculated with 
all three strains of BSE and paralleled levels of PrPSc accumulation in the tissue. Thus, our results 
collectively suggest a relationship between shorter incubation times, greater accumulation of PrPSc, and 
evidence of neuroinflammation. 
Activation of the NLRP3 inflammasome parallels the shorter incubation times of atypical BSE-H and 
BSE-L   
Contribution of NLRP3 inflammasome activation to the progression of protein misfolding diseases has 
been extensively described in TSEs, PD, and AD 22. To probe the relationship between incubation time 
and NLRP3 inflammasome activation in BSE, we assessed the expression of key inflammasome 
components: NACHT, LRR and PYD domains-containing protein 3 (NLRP3), the adaptor molecule 
apoptosis-associated speck-like protein containing a CARD (ASC), active caspase-1, and active IL-1β (Fig. 
4). NLRP3 immunoreactivity in the retinas of control cattle was negligible (Fig. 4A). Retinas from cattle 
inoculated with classical BSE had increased NRLP3 immunoreactivity, and similar to Iba1 
immunoreactivity, it was localized to the synaptic layers (Fig. 4B). Retinas of cattle inoculated with 
atypical BSEs, had robust NLRP3 immunoreactivity, with approximately a two-fold increase compared to 
classical BSE (Fig. 4C-E). Double immunofluorescence and confocal microscopy confirmed that NLRP3 
was almost exclusively localized to Iba1+ microglia, consistent with previous reports linking the 
detrimental effects of chronic microgliosis to inflammasome activation 21, 23, 37. Immunohistochemical 
analysis of ASC immunoreactivity, yielded similar results (Fig. 4I-M). In contrast to NLRP3 expression, 
however, negligible multifocal ASC immunoreactivity was observed in the retinas from cattle inoculated 
with classical BSE (p > .05 versus control) (Fig. 4I, J, M). Retinas from cattle inoculated with atypical BSEs 
had significantly more ASC immunoreactivity (~eight-fold increase), compared to the retinas from cattle 
in the sham or classical BSE inoculated groups (Fig. 4K-M). Assembly of the NLRP3 inflammasome 
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triggers cleavage of procaspase-1 into active caspase-1 that converts the cytokine precursor pro-IL-1β 
into active IL-1β, a key proinflammatory mediator 38. Western blot analysis of downstream 
inflammasome markers, active caspase-1 and IL-1β, showed minimal protein expression in retinas from 
cattle in either the sham or classical BSE inoculation groups (p > 0.05) (Fig. 4N-P). In comparison, the 
retinas from cattle inoculated with atypical BSEs had a significant increase in both caspase-1, and IL-1β 
protein expression (Fig. 4N-P).  
Similar results were observed in the brainstem at the level of the obex, thalamus, and caudate nucleus 
(Supp. Fig. S3 and Supp. Fig. S4). Consistent with results from the retina, double immunofluorescence 
and confocal microscopy confirmed that NLRP3 was localized to Iba1+ microglia in the obex (Supp. Fig. 
S3A-C), thalamus (data not shown), and caudate nucleus (data not shown). The obex and thalami from 
cattle inoculated with BSE-H or BSE-L had significantly more NLRP3 (Supp. Fig. S3D, E) and ASC (Supp. 
Fig. S3G, H) immunoreactivity compared to cattle inoculated with sham or classical BSE. Levels of NLRP3 
and ASC immunolabeling in the caudate nucleus was comparable in cattle inoculated with either 
classical BSE, BSE-H, or BSE-L. The obex, and thalami from cattle inoculated with BSE-H and BSE-L, also 
had higher expression of caspase-1 (Supp. Fig. S4A, B, D) and IL-1β (Supp. Fig. S4A, C, E), compared to 
cattle inoculated with sham or classical BSE. Protein expression levels of caspase-1 (Supp. Fig. S4A, F) 
and IL-1β (Supp. Fig. S4A, G) in the caudate nucleus was comparable in classical BSE, BSE-H, and BSE-L. 
These results demonstrate increased microglia-driven NALP3 inflammasome activation in cattle 
inoculated with atypical BSEs, that parallels increased PrPSc accumulation and shorter disease incubation 
times.  
 
Autophagic progression is impaired in atypical BSE-H and BSE-L  
In protein misfolding diseases, an increase in autophagy is a proper response during clearing of bulk 
cytoplasmic contents. A decrease below basal levels may indicate autophagic dysfunction due to an 
overload of a system incapable of degrading proteins 39-42. To assess the relationship between incubation 
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time and autophagy in the retina, we performed immunohistochemical and Western blot analysis of 
proteins involved in the initiation of autophagy and vesicle formation (Fig. 5). To determine changes in 
vesicle formation, we analyzed distribution, and protein expression of the autophagosome marker, LC3. 
Retinas from cattle from the sham and classical BSE inoculation groups had diffuse LC3 
immunoreactivity localized to the outer segments and synaptic layers consistent with a basal level of 
autophagy under normal conditions (Fig. 5A). Retinas from cattle inoculated with classical BSE had 
robust, multifocal LC3-immunoreactivity primarily in the synaptic layers similar to the pattern of PrPSc 
immunoreactivity in these cattle (Fig. 5B). In contrast, retinas from cattle inoculated with atypical BSE-H 
and BSE-L, had inappreciable and diffuse LC3 immunoreactivity, comparable to retinas from control 
cattle (Fig. 5C, D). Western blot analysis of LC3-II protein expression revealed similar results. Compared 
to control, level of LC3-II protein expression was ~2-fold higher in retinas from classical BSE cattle 
(p>0.001), and comparable in retinas of BSE-H (p>0.05) and BSE-L (p>0.05) cattle (Fig. 5E, F).  
To determine changes in the initiation of autophagy, we examined expression levels of the key 
autophagy-initiation protein, pULK1S757. Briefly, the initiation stage involves activation of ULK1 (a serine-
threonine kinase), regulated by both mTOR and AMPK. Activation of mTOR leads to the enzymatic 
inactivation of ULK1, by downstream phosphorylation at serine 757. Conversely, when AMPK is 
activated, ULK1 is dephosphorylated at Serine 757 and thereby activated allowing for autophagy to 
advance 43. Compared to control, protein levels of pULK1S757 were significantly lower in retinas from 
cattle inoculated with classical BSE (Fig. 5E, G). Protein levels of pULK1S757 in retinas from cattle 
inoculated with BSE-H and BSE-L, were comparable to basal levels detected in retinas from sham-
inoculated cattle (Fig. 5E, G). Again, similar results were observed in the brainstem, thalamus, and 
caudate nucleus (Supp. Fig. S5). The brainstem, and thalami from cattle inoculated with BSE-H and BSE-
L, had significantly higher expression of LC3II (Supp. Fig. S5A, B, D), and lower expression of pULK1S757 
(Supp. Fig. S5A, C, E). However, protein expression levels of LC3II (Supp. Fig. S5A and F), and pULK1S757 
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(Supp. Fig. S5A and G) in the caudate nucleus were similar in tissues from cattle inoculated with classical 
BSE, BSE-H, or BSE-L. These results indicate an inverse relationship between incubation period and 
autophagy, suggesting that that autophagic dysfunction may contribute to increased PrPSc accumulation 
in atypical BSEs, leading to an accelerated disease phenotype and shorter incubation periods.  
Taken together, we report an inverse correlation between incubation time and NLRP3 inflammasome 
activation, and a positive correlation between incubation period and autophagy (Fig. 6). Our work 
suggests a reciprocal regulation between PrPSc-associated neuroinflammation and autophagy in vivo 
that reflects differences in incubation period and disease progression.   
DISCUSSION 
In this study, we report a relationship between strain-dependent differences in disease incubation 
period and accumulation of PrPSc in the retina, brainstem, and thalamus. Specifically, cattle inoculated 
with the agents of atypical BSE-H or BSE-L had shorter incubation periods and greater areas of PrPSc 
deposition compared to cattle inoculated with classical BSE demonstrating a negative relationship 
between incubation period and disease pathology. Prion disease strains can be differentiated by 
incubation periods, neuroanatomical and cellular deposition patterns of PrPSc, and other molecular 
properties 5-8, 44, 45. Distinct prion strains, within a species, have been shown to exhibit different patterns 
and levels of PrPSc accumulation in the brain independent of incubation period. For example, PrPSc 
deposition in classical scrapie in sheep occurs primarily in the medulla oblongata rather than the cortices 
of the cerebellum and the cerebrum as seen in atypical sheep scrapie 4, 7, 46. Additionally, spongiform 
lesions and PrPSc immunoreactivity in the brains from cattle inoculated with classical BSE are distinct 
from that of cattle with atypical BSE-H. In natural and experimental cases of classical BSE, spongiform 
lesions are distributed consistently throughout the brain 47, whereas in BSE-H, spongiform lesions and 
PrPSc immunoreactivity are more intense in the brainstem and midbrain, increasing in intensity caudally, 
from the frontal cortex to the occipital cortex 16, 35, 47. Moreover, patterns of PrPSc immunoreactivity (i.e., 
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intraglial, stellate, intraneuronal, etc.) in the brains from BSE-H and classical BSE affected cattle, vary 
depending upon region 16, 35. While strain-dependent patterns of PrPSc accumulation have been widely 
explored, studies examining the relationship between strain-dependent incubation period and extent of 
PrPSc deposition are lacking.  
Historically, glial activation has been assumed to be merely a response to pathophysiological events in 
protein-misfolding diseases, however, more recent studies have established key contributions of glial 
cells to neuroinflammation and neurodegenerative disease pathogenesis (reviewed in 48). While this 
study does not prove a causal relationship, this work describes a positive correlation between glial cell 
activation and PrPSc accumulation that is reflected in disease incubation period. Compared to cattle with 
classical BSE, the retinas from cattle inoculated with atypical BSEs (BSE-H and BSE-L) had robust 
activation of Müller glia that paralleled intense PrPSc accumulation and shorter incubation periods. 
Müller glia, which are normally quiescent, are ubiquitously activated in response to a wide range of 
pathogenic stimuli, exerting protective and toxic effects on retinal neurons. Although activation of 
Müller glia has been previously reported in BSE 13, and other prion diseases 12, the relationship between 
incubation period and Müller glial activation in the retina has not been previously described. 
Examination of several brain regions demonstrated that compared to classical BSE, the brainstems and 
thalami from cattle inoculated with atypical BSEs had more intense activation of astrocytes that 
paralleled PrPSc accumulation. However, levels of astrocyte activation in caudate nuclei were 
comparable in classical and atypical BSEs. The close association of activated astrocytes and PrPSc 
deposits is well documented in prion disease further supporting our results 49-51.  
Here, we demonstrate an association between strain-dependent incubation period, PrPSc accumulation, 
and microglial activation in vivo. Our results show that compared to classical BSE, retinas from cattle 
inoculated with atypical BSEs, had altered microglial morphology and robust activation that also 
paralleled intense PrPSc accumulation and shorter incubation periods. We see a similar relationship in 
Running title: Retinal changes in prion disease 
 
 
the brainstem and thalamus, but not in the caudate nucleus. The molecular mechanisms underlying the 
microglial response to PrPSc are still largely unknown. Previous work reported that the depletion of 
microglia resulted in enhanced PrPSc accumulation and augmented prion infectivity suggesting a 
neuroprotective role 52. Several time course studies reported that the onset of microglial activation 
occurs at an early pre-clinical phase of prion disease, before spongiform change and/or neuronal loss, 
indicating that microglia may contribute to PrPSc-induced neurodegeneration 12, 53-55. The current study 
shows that the distribution of microglial response positively correlates with PrPSc deposition indicating a 
negative relationship between incubation period and microglial activation. Several murine models of 
prion disease describe the role of microglia in prion pathogenesis highlighting shortened or prolonged 
disease incubation period and augmented PrPSc accumulation as a common effect of modulating 
microglia-related molecules (i.e., toll-like receptors, cytokines and chemokines, complement systems, 
etc.) (reviewed in 56). The detrimental effects of microglial activation in prion disease also were 
investigated in the context of NALP3 inflammasome activation 21, 22. The NALP3 inflammasome is a 
multiprotein complex that has been shown to be activated by PrP fibrils leading to the secretion of IL-1β 
and other proinflammatory factors 21, 23-25. Our results demonstrate robust NLRP3 inflammasome 
activation in the retinas from cattle inoculated with BSE-H or BSE-L as evidenced by a significant 
upregulation of key inflammasome proteins (i.e., NLRP, ASC, active-caspase-1, and active-IL-1β). Retinas 
from cattle inoculated with classical BSE had minimal NLRP3 and ASC immunoreactivity, while protein 
expression levels of downstream inflammatory mediators, caspase-1 and IL-1β, were comparable to 
controls. While previous research has identified several independent mechanisms at play in regard to 
NALP3 inflammasome activation in response to PrP fibrils, this is the first report that describes the 
relationship between incubation period, PrPSc accumulation, and NLRP3 inflammasome activation in a 
natural host of prion disease 21, 22, 57.  
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Our work describes contrasting events in the autophagic pathway: upregulation of autophagy in the 
retinas from cattle inoculated with classical BSE indicated by the increase in LC3II, decrease in pULK1S757, 
and downregulation of autophagy in the retinas from cattle inoculated with BSE-H and BSE-L. Recently, 
it was reported that the inhibition of autophagy enhances release of active IL-1β, and inversely, gene 
silencing of the NALP3 inflammasome promotes autophagy in an in vitro prion model 26. In the current 
study, upregulation of autophagy in classical BSE, paralleled longer incubation periods (~640 dpi). 
Conversely, downregulation of autophagy correlated with robust PrPSc accumulation, NLRP3 
inflammasome activation, and shorter incubation periods (~490 dpi). The neuroprotective role of 
autophagy is suggested by several studies demonstrating that the upregulation of autophagic flux can 
clear misfolded and aggregated intracellular proteins and suppress neuroinflammation via the 
degradation of IL-1β 40, 58-66. While numerous studies show the upregulation of autophagosomes in 
response to misfolded proteins in neurodegenerative diseases (i.e. prion disease, PD, and AD), whether 
this event is a proper response to accumulation of misfolded proteins or due to an impairment in the 
degradation of autophagosomes, is not known 33. Further, it is unknown whether an impairment in the 
degradation of misfolded proteins is yet another factor that leads to protein aggregation or whether 
autophagic dysfunction is driven by misfolded proteins. This work demonstrates an inverse relationship 
between neuroinflammation and autophagy in vivo that is strain-dependent and is reflected in disease 
incubation period. In line with our work, a recent study investigated autophagic regulation at different 
stages of scrapie in ovinized Tg338 mice and reported that autophagic dysregulation may be part of the 
pathologic process of scrapie, evident in the late stage of prion infection. 67   
A hallmark of prion diseases and other neurodegenerative proteinopathies is the formation of misfolded 
protein aggregates that cause neuroinflammation and cellular toxicity that contribute to cellular 
collapse. Therapeutic options that are being explored target different steps in the synthesis, processing, 
and degradation of proteins implicated in neurodegenerative diseases. A major challenge that impacts 
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the development of therapies is the incomplete knowledge of factors that influence disease progression. 
The strain-dependent variation in incubation periods between classical and atypical BSEs provides a 
unique platform to investigate the molecular underpinnings that lead to an accelerated disease 
progression in atypical BSEs as compared to classical BSE. Herein, we describe the relationship between 
incubation period, PrPSc accumulation, microglia-driven NLRP3 inflammasome activation, and autophagy 
that has not been previously reported in natural host of prion disease. Targeting potential mechanisms 
of several NLRP3 inflammasome inhibitors has been increasingly regarded as an effective approach to 
developing therapies for PD, AD, and HD 68-72. Inhibition of macroautophagy is widely shown to be a 
contributing factor in several proteinopathies, therefore, upregulation of autophagy has also been 
regarded as a valuable therapeutic strategy (reviewed in 73). The roles of gliosis, the NLRP3 
inflammasome, and protein clearance via macroautophagy all have been individually studied in the 
pathogenesis and progression of several protein misfolding diseases including prion disease, PD, AD, and 
HD 68-72. This study provides a unique framework for understanding an interconnected system in which 
the progression of protein misfolding disease is affected by the amount of misfolded proteins in the 
tissue, the corresponding neuroinflammatory response, and the protein-clearance system.  
Collectively, this study describes several key relationships between strain-dependent incubation period, 
PrPSc accumulation, neuroinflammation, and the autophagic stress response. A caveat of this study is 
that it does not investigate the role of differing amounts of infectivity in the three BSE isolates, therefore 
it is possible that these observations are in part due to the amount of infectivity in the inocula and not 
just the inherent biological potency of each strain. We demonstrate that the retinas from cattle 
inoculated with atypical BSEs (BSE-H and BSE-L), characterized with shorter incubation periods 
compared to classical BSE, have robust PrPSc accumulation. Greater PrPSc accumulation in these cattle 
corresponds to significantly increased retinal glial cell activation and microglia-driven NRLP3 
inflammasome activation that also is a reflected in a shorter incubation period. Finally, we report that 
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increased PrPSc accumulation and NLRP3 activation coincide with the down-regulation of autophagy and 
shorter incubation periods. Our findings support and further clarify a previously reported mechanism 
describing the interconnection of neuroinflammation and autophagy in response to prion disease. We 
describe the relationship between strain-dependent misfolded protein accumulation, 
neuroinflammation, and autophagy in vivo in a natural host of prion disease that may be predictors of 
disease incubation period. These results should advance our understanding of the interaction between 
disease pathogenesis and prion strain dependent incubation periods, and help identify new potential 
therapeutic targets for intervention.  
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Fig. 1 Incubation periods of classical and atypical BSEs. Kaplan Meier survival curve showing the average 
incubation period defined as the number of days from inoculation to the onset of unequivocal clinical 
signs for cattle inoculated with the classical BSE (n=12) mean, BSE-H (n=9), or BSE-L (n=10) agents. Data 
are expressed as mean ± SEM. Abbreviations: dpi, days post inoculation.  
Fig. 2 Accumulation of PrPSc in tissues from cattle with classical BSE, BSE-H, or BSE-L. A: The retinas from 
negative control cattle had no PrPSc immunoreactivity. B: The retinas from cattle inoculated with 
classical BSE had PrPSc immunoreactivity localized to the OPL and IPL. C, D: The retinas from cattle 
inoculated with BSE-H or BSE-L had increased PrPSc immunoreactivity in all retinal layers. E-H: Brainstem 
at the level of the obex (hypoglossal nucleus) from cattle inoculated with BSE-H or BSE-L had more PrPSc 
immunoreactivity compared to cattle inoculated with classical BSE. i-l Thalamus (interthalamic nuclei) 
from cattle inoculated with BSE-H or BSE-L had more PrPSc immunoreactivity compared to that from 
cattle inoculated with classical BSE. M-P: PrPSc immunoreactivity in the caudate nuclei from cattle 
inoculated with the BSE-H or BSE-L agents was comparable to classical BSE. Abbreviations: GCL, ganglion 
cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer 
nuclear layer; PR, photoreceptor layer. Scale bars: 40 µm.  
Fig. 3 Activation of retinal glial cells. A: GFAP is localized to end feet of Müller glia in retinas of control 
cattle. B: Distribution of GFAP immunoreactivity is increased in the retinas of cattle with classical BSE. 
Immunoreactivity spans the retina from the GCL to the OPL. C, D: The retinas from cattle inoculated with 
BSE-H or BSE-L have significantly increased GFAP immunoreactivity spanning the entire retinal thickness. 
E, F: Iba-1 immunolabeled microglia in the retinas from cattle inoculated with classical BSE are quiescent 
with long processes and small cell bodies that are localized primarily to the plexiform layers. G, H: 
Robust microglial activation is evident in retinas of BSE-H or BSE-L inoculated cattle. Iba1 positive 
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microglia have larger cell bodies, thicker/retracted processes, and are localized to the synaptic and 
nuclear layers. I, J: Bar graphs show significant increase in GFAP and Iba1 immunoreactivity in retinas of 
cattle inoculated with classical BSE, BSE-H, and BSE-L. Data are expressed as mean ± SEM. 
Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer 
plexiform layer; ONL, outer nuclear layer; PR, photoreceptor layer. Scale bars: 40 µm. ****P < 0.0001 
versus control; ††††P < 0.0001 versus classical BSE; ††P < 0.01 versus classical BSE; †P < 0.05 versus 
classical BSE.  
Fig. 4 NALP3 inflammasome activation. A-M: Immunohistochemical analysis of key inflammasome 
components that are upregulated in cattle inoculated with BSE-H or BSE-L compared to cattle inoculated 
with classical BSE: A-H: NLRP3 and I-M: ASC. E, M: Bar graphs show percent area of fluorescence for 
NLRP3 and ASC. Data are expressed as mean ± SEM. F-H: Colocalization of Iba1+ microglia and NLRP3 
confirming presence of NLRP3 inflammasome in activated, hypertrophic microglia. Abbreviations: GCL, 
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, 
outer nuclear layer; PR, photoreceptor layer. Scale bars: 40 µm. ****P < 0.0001 versus control; ††††P < 
0.0001 versus classical BSE. N: Western blot analysis of cleaved caspase-1 (p20) and cleaved IL-1β (p17) 
expression levels in the retina. To highlight the band of interest, blots were cropped from different parts 
of the same gel, or from different gels, with consistent exposure times. Data is not spliced together from 
different gels. O, P: Representative bar graphs showing quantitative densitometric analysis of cleaved 
caspase-1 (p20) ± SEM, and cleaved IL-1β (p17) ± SEM in retinas of cattle inoculated with sham, classical 
BSE, BSE-H, and BSE-L. ***P < 0.0001 versus control; †††P < 0.001 versus classical BSE; ****P < 0.0001 
versus control; ††††P < 0.0001 versus classical BSE.  
Fig. 5 Strain-dependent changes in macroautophagy. A: Diffuse LC3 immunoreactivity in the retinas from 
negative control cattle is representative of basal autophagy. B: Increase in LC3-immunoreactive 
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autophagosomes in outer segments of photoreceptor cells, outer and inner plexiform layers, and 
ganglion cell layer evident in retinas from cattle inoculated with classical BSE is suggestive of autophagic 
response to misfolded protein (PrPSc) accumulation. C, D: Retinas from cattle inoculated with BSE-H or 
BSE-L have lack of LC3-immunoreactive puncta similar to control retinas. Abbreviations: GCL, ganglion 
cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer 
nuclear layer; PR, photoreceptor layer. Scale bars: 40 µm. Data are expressed as means ± SEM. E: 
Western blot analysis of LC3II, pULK1S757, and ULK1 expression levels in the retina. To highlight the band 
of interest, blots were cropped from different parts of the same gel, or from different gels, with 
consistent exposure times. Data is not spliced together from different gels. F, G: Representative bar 
graphs showing quantitative densitometric analysis of LC3 II ± SEM, and pULK1S757/ULK1 ± SEM. *P < 
0.05 versus control; ***P < 0.001 versus control; †††P < 0.001 versus classical BSE. 
Fig. 6 Reciprocal regulation between neuroinflammation and autophagy is reflected in incubation 
periods. A: Graph represents a negative relationship between disease incubation period and 
neuroinflammation (represented by % fluorescence of NLRP3 immunoreactivity, also shown in Fig. 4) in 
retinas from cattle inoculated with classical BSE, BSE-H, or BSE-L. B: Graph represents a negative 
relationship between disease incubation period and autophagy (represented by LC3II protein 
expression, also shown in Fig. 5) in retinas from cattle inoculated with classical BSE, BSE-H, or BSE-L. 






